Urology · Los Angeles, CA
NPI
1255390464
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8631 W 3rd St Ste 1115
Los Angeles, CA, 90048
Phone (310) 278-8330
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
235,821 services
Medicare patients, 2024
1,209
Average age 76
Drug cost, 2024
$2.5M
5,061 prescriptions
Company payments, 2025
$1,633
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kiarash N Michel was code J1071 (injection, testosterone cypionate, 1 mg), 152,486 times for 144 patients. In total Kiarash N Michel billed 235,821 services in 173 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 152,486 | 144 | $0.02 | $2,819 |
| 87798 Infectious Agent Detection by DNA/RNA | Office | 7,940 | 367 | $34.34 | $273K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 3,020 | 365 | $34.28 | $104K |
| 99214 Office E&M - Established | Office | 2,853 | 1,036 | $100.66 | $287K |
| 81001 Clinical Chemistry | Office | 2,290 | 1,012 | $3.09 | $7,072 |
| 87801 Infectious Agent Detection by DNA/RNA | Office | 1,768 | 357 | $68.80 | $122K |
| 84403 Clinical Chemistry | Office | 1,465 | 872 | $24.99 | $37K |
| 84270 Clinical Chemistry | Office | 1,465 | 871 | $21.04 | $31K |
| 84402 Clinical Chemistry | Office | 1,465 | 871 | $24.65 | $36K |
| 36415 Venipuncture Blood Collection | Office | 1,463 | 834 | $8.56 | $13K |
| 82670 Clinical Chemistry | Office | 1,460 | 869 | $27.04 | $39K |
| 82627 Clinical Chemistry | Office | 1,458 | 870 | $21.52 | $31K |
| 83001 Clinical Chemistry | Office | 1,457 | 868 | $17.99 | $26K |
| 83002 Clinical Chemistry | Office | 1,455 | 867 | $17.93 | $26K |
| 96372 Injection Administration | Office | 1,452 | 175 | $11.76 | $17K |
By year: 2022 $2.1M for 187,504 services; 2023 $2.2M for 203,040 services; 2024 $2.5M for 235,821 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 7,940 | 367 | $34.34 | $273K |
| 87481 Infectious Agent Detection by DNA/RNA | 3,020 | 365 | $34.28 | $104K |
| 81001 Clinical Chemistry | 2,290 | 1,012 | $3.09 | $7,072 |
| 87801 Infectious Agent Detection by DNA/RNA | 1,768 | 357 | $68.80 | $122K |
| 84270 Clinical Chemistry | 1,465 | 871 | $21.04 | $31K |
| 84402 Clinical Chemistry | 1,465 | 871 | $24.65 | $36K |
| 84403 Clinical Chemistry | 1,465 | 872 | $24.99 | $37K |
| 36415 Venipuncture Blood Collection | 1,463 | 834 | $8.56 | $13K |
| 82670 Clinical Chemistry | 1,460 | 869 | $27.04 | $39K |
| 82627 Clinical Chemistry | 1,458 | 870 | $21.52 | $31K |
Medicare prescription drug claims, 2024
In 2024, the drug Kiarash N Michel prescribed most often to Medicare patients was Tadalafil, with 567 prescriptions and refills. In total Kiarash N Michel wrote 5,061 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tadalafil Generic | 567 | 971 | 126 | $58K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 459 | 1,022 | 142 | $10K |
| Dutasteride Generic | 427 | 801 | 113 | $9,651 |
| Tamsulosin Hcl Generic | 414 | 961 | 126 | $6,423 |
| Gemtesa Vibegron | 379 | 635 | 100 | $299K |
| Xyosted Testosterone Enanthate | 312 | 334 | 54 | $203K |
| Silodosin Generic | 294 | 529 | 82 | $19K |
| Testosterone Cypionate Generic | 265 | 301 | 57 | $8,849 |
| Methenamine Hippurate Generic | 159 | 246 | 40 | $9,601 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 158 | 158 | 123 | $639 |
| Testosterone Generic | 142 | 166 | 38 | $14K |
| Finasteride Generic | 104 | 277 | 38 | $1,572 |
| Clomid Clomiphene Citrate | 99 | 160 | 24 | $16K |
| Myrbetriq Mirabegron | 93 | 147 | 24 | $65K |
| Ciprofloxacin Hcl Generic | 92 | 92 | 64 | $321 |
Brand drugs: - claims; generic drugs: 4,038 claims; opioid claims: 81.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kiarash N Michel $1,633 ($1,633 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $155 |
| Janssen Biotech, Inc. JNJ | 7 | $144 |
| Telix Pharmaceuticals TLX | 6 | $136 |
| Pfizer Inc. PFE | 6 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $108 |
| Urogen Pharma, Inc. URGN | 2 | $103 |
| Dendreon Pharmaceuticals LLC | 4 | $102 |
| Verity Pharmaceuticals Inc. | 3 | $94.99 |
| Antares Pharma, Inc. | 4 | $91.01 |
| Immunitybio, Inc. IBRX | 3 | $74.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.